Stockscreener 앱 받기
6.30
10.14%
0.58
시간 외 거래:
6.31
0.010
+0.16%
전일 마감가:
$5.72
열려 있는:
$5.72
하루 거래량:
510.56K
Relative Volume:
1.15
시가총액:
$135.40M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-4.0645
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
+13.92%
1개월 성능:
+22.81%
6개월 성능:
+1,039%
1년 성능:
+967.62%
1일 변동 폭
$5.72
$6.365
1주일 범위
$5.1409
$6.365
52주 변동 폭
$0.45
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
6.30 | 122.93M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Guggenheim | Buy |
| 2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Unicycive Therapeutics Inc. stock a top momentum playJuly 2025 Reactions & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Unicycive Therapeutics to Participate in Upcoming Investor Events in December - 富途牛牛
Unicycive Therapeutics (Nasdaq: UNCY) to join Piper Sandler and Noble investor events - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive The - The National Law Review
Can Unicycive Therapeutics Inc. stock double in next 5 yearsJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Sentiment analysis tools applied to Unicycive Therapeutics Inc.Options Play & Long-Term Capital Growth Ideas - newser.com
Will Unicycive Therapeutics Inc. stock maintain growth storyQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Can Unicycive Therapeutics Inc. stock attract ESG capital inflowsWatch List & Daily Chart Pattern Signals - newser.com
What moving averages say about Unicycive Therapeutics Inc.Weekly Trade Analysis & Consistent Growth Stock Picks - newser.com
What catalysts could drive Unicycive Therapeutics Inc. stock higherEarnings Overview Report & Precise Buy Zone Tips - newser.com
How rising interest rates impact Unicycive Therapeutics Inc. stockWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well - Yahoo Finance
Unicycive Therapeutics, Inc.Common Stock (NQ: UNCY - Markets Financial Content
How Unicycive Therapeutics Inc. stock compares to growth peersJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Can Unicycive Therapeutics Inc. stock hit analyst price targets2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Live market analysis of Unicycive Therapeutics Inc.July 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Should you hold or exit Unicycive Therapeutics Inc. nowWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.16%
자본화:
|
볼륨(24시간):